StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health AFS Fixed Maturity Securities — Total Fair Value by Quarter

AFS Fixed Maturity Securities — Total Fair Value ($M)

QuarterlyAnnual

Elevance Health AFS Fixed Maturity Securities — Total Fair Value: $26,558M in Q3 2026, down 3.1% from a year earlier.

Latest, Q3 2026
26,558
Period ended Sep 30, 2026
Change on a year earlier
-3.1%
27,394 in Q3 2025
History
18 quarters
Since Q4 2021
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:AvailableForSaleSecuritiesDebtSecurities (2026-09-30): 26,558,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Fixed Maturity Securities — Total Fair Value ($M)Year on yearSource
Q3 2026Sep 30, 202626,558-3.1%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2026Jun 30, 202626,978+2.2%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2026Mar 31, 202627,019+2.0%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2025Dec 31, 202527,005+2.9%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2025Sep 30, 202527,394-8.2%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2025Jun 30, 202526,385-11.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2025Mar 31, 202526,497-12.9%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2024Dec 31, 202426,236-14.0%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2024Sep 30, 202429,847+4.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2024Jun 30, 202429,749+3.3%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2024Mar 31, 202430,410+7.0%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2023Dec 31, 202330,490+14.2%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q3 2023Sep 30, 202328,627+9.5%ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q2 2023Jun 30, 202328,796–ELV 10-Q/A (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q1 2023Mar 31, 202328,419–ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
Q4 2022Dec 31, 202226,704-0.7%ELV 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗

Breakdown

What makes up AFS Fixed Maturity Securities — Total Fair Value

Cite this data

StockData. (2026). Elevance Health AFS Fixed Maturity Securities — Total Fair Value ($M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-afs-debt-fair-value

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.